STAT+: Which biotechs are affected by the government shutdown?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. I can’t believe it either, but we’re in the fourth quarter of the year. We’ve got a guide for you on the key events to watch this quarter, but first, we’ll take you through the news today.
U.K. antitrust regulator is asked to probe drugmakers’ investment halts
Patient advocacy groups asked the U.K.’s antitrust regulator to investigate several large drugmakers and their lobbying organization for what they argued looks to be a coordinated effort to drive up the prices of medicines.
Elaine Chen
Go to statnews